Recruiting OBSERVATIONAL NCT05375149

Exhaled Breath Particles in Lung Transplantation

Exhaled Breath Particles as a Clinical Indicator for Acute and Chronic Rejection After Lung Transplantation

Sponsor: Lund University Hospital

Conditions Chronic Rejection of Lung Transplant Lung Transplant Rejection Primary Graft Dysfunction

Updated 3 times since 2022 Last updated: May 10, 2022 Started: Sep 18, 2018 Primary completion: Sep 30, 2024 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Rejection of Lung Transplant and Lung Transplant Rejection, this trial is actively recruiting participants. The trial is conducted by Lund University Hospital and has accumulated 3 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2022 — Jul 2024 [monthly]

Recruiting

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lund University Hospital

Data source: Lund University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lund, Sweden